COVID-19 Increases Odds of Developing A-Fib
It’s unfortunate but we have to add developing A-Fib to the list of effects of having COVID-19.
A retrospective study from the Mass General Brigham hospital system in Boston studied the risk of hospitalized COVID patients to develop onset of atrial fibrillation. The study used data from between March 1, 2020 and February 28, 2021 and matched 11,004 COVID-19 negative patients to 2,283 COVID-19 positive patients.
They found that COVID-19 positive patients had 19% higher odds of developing Atrial Fibrillation compared to COVID-19 negative patients. And 57% higher odds of developing A-Fib compared to pre-pandemic patients.
Sad to say, during this world-wide pandemic, a greater risk of developing Atrial Fibrillation is yet another fallout of COVID-19 disease.
Treatment for Familial A-Fib: We know that Atrial Fibrillation runs in families. Recent data suggests that up to 30% of atrial fibrillation patients may have a family history of the condition. This includes offspring too.
If you have A-Fib and a blood relative develops COVID-19, there is treatment to reduce their chance of developing A-Fib. An antiarrhythmic medication can be prescribed on a temporary basis to prevent or better control early on-set A-Fib. Talk with them and their doctor about this treatment.
A-Fib Patients: When you have A-Fib, the risk for complications is elevated. Get vaccinated against COVID-19 and keep up with your booster shots. To avoid making your A-Fib worse, do everything you can to avoid catching COVID-19.
Related Posts
AUTHOR PROFILE
Our Mission
What Do We Stand For?
Learn moreWe Need You
Help A-Fib.com be an independent source for unbiased patient information.
Support via Amazon
Shop using our linkSupport Our Work
